FDA Classifies Transcutaneous Electrical Nerve Stimulator for Congestion Relief

Summary

The FDA is classifying the transcutaneous electrical nerve stimulator for the relief of congestion into Class II, citing a reasonable assurance of safety and effectiveness, and aims to reduce regulatory burdens, enhancing patients' access to innovative devices.